These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Neurological complications and Japanese encephalitis vaccination. Plesner AM; Arlien-Søborg P; Herning M Lancet; 1996 Jul; 348(9021):202-3. PubMed ID: 8684185 [No Abstract] [Full Text] [Related]
44. Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study. Schuller E; Klade CS; Wölfl G; Kaltenböck A; Dewasthaly S; Tauber E Vaccine; 2009 Mar; 27(15):2188-93. PubMed ID: 19200452 [TBL] [Abstract][Full Text] [Related]
45. Adverse reactions to Japanese encephalitis vaccine. Ruff TA; Eisen D; Fuller A; Kass R Lancet; 1991 Oct; 338(8771):881-2. PubMed ID: 1681228 [No Abstract] [Full Text] [Related]
46. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. Kumar R; Tripathi P; Rizvi A N Engl J Med; 2009 Apr; 360(14):1465-6. PubMed ID: 19339732 [No Abstract] [Full Text] [Related]
47. Japanese B encephalitis vaccine. Time for a reappraisal? Ruff TA Med J Aust; 1994 Oct; 161(8):511. PubMed ID: 7802832 [No Abstract] [Full Text] [Related]
48. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection. Pugachev KV; Mason PW; Shope RE; Frey TK Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428 [TBL] [Abstract][Full Text] [Related]
49. Japanese encephalitis revisited. Diagana M; Preux PM; Dumas M J Neurol Sci; 2007 Nov; 262(1-2):165-70. PubMed ID: 17643451 [TBL] [Abstract][Full Text] [Related]
50. Selection of immunodominant fragments from envelope gene for vaccine against Japanese encephalitis virus in DNA priming-protein boosting protocols. Chen CT; Yi YC; Chiang SC; Liu KC; Lin YL; Lee ST Microb Pathog; 2005; 38(2-3):53-62. PubMed ID: 15748807 [TBL] [Abstract][Full Text] [Related]
51. Japanese encephalitis vaccine: an orphan product in need of adoption. McKinney WP; Barnas GP N Engl J Med; 1988 Jan; 318(4):255-6. PubMed ID: 2827028 [No Abstract] [Full Text] [Related]
52. Anaphylaxis to Japanese encephalitis vaccine. Sakaguchi M; Nakashima K; Takahashi H; Nakayama T; Fujita H; Inouye S Allergy; 2001 Aug; 56(8):804-5. PubMed ID: 11488694 [No Abstract] [Full Text] [Related]
53. [The influence of the season of birth on preventive efficacy of the Japanese encephalitis vaccine (author's transl)]. Miura T; Tamura H; Shimura M Nihon Eiseigaku Zasshi; 1976 Oct; 31(4):520-4. PubMed ID: 190430 [No Abstract] [Full Text] [Related]
54. Further experience with Japanese encephalitis vaccine. Sanchez JL; Hoke CH; McCown J; DeFraites RF; Takafuji ET; Diniega BM; Pang LW Lancet; 1990 Apr; 335(8695):972-3. PubMed ID: 1970043 [No Abstract] [Full Text] [Related]
55. Japanese encephalitis in a Danish short-term traveler to Cambodia. Werlinrud AM; Christiansen CB; Koch A J Travel Med; 2011; 18(6):411-3. PubMed ID: 22017718 [TBL] [Abstract][Full Text] [Related]
56. [Hemagglutination inhibition antibody against Japanese encephalitis virus and the effects of vaccination on inhabitants of Fukuoka City and its environs]. Kobayashi Y; Ichiki T; Kusaba T; Tachibana N; Nagai K Kansenshogaku Zasshi; 1971 Nov; 45(11):490-3. PubMed ID: 4336811 [No Abstract] [Full Text] [Related]
57. [Levels of HI antibody against Japanese encephalitis virus and the effect of vaccination in inpatients of a tuberculosis sanatorium in Fukuoka City]. Kusaba T; Ichiki T; Nagai K; Tachibana N; Matsumoto I Kansenshogaku Zasshi; 1972 Jul; 46(7):240-5. PubMed ID: 4347344 [No Abstract] [Full Text] [Related]
58. Japanese encephalitis: a Chinese solution? Steinhoff MC Lancet; 1996 Jun; 347(9015):1570-1. PubMed ID: 8667861 [No Abstract] [Full Text] [Related]
59. Liability for vaccine-related injuries. Marcus LC N Engl J Med; 1988 Jan; 318(3):191-2. PubMed ID: 2827027 [No Abstract] [Full Text] [Related]